» Articles » PMID: 24465923

Identification of Human Disease Genes from Interactome Network Using Graphlet Interaction

Overview
Journal PLoS One
Date 2014 Jan 28
PMID 24465923
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Identifying genes related to human diseases, such as cancer and cardiovascular disease, etc., is an important task in biomedical research because of its applications in disease diagnosis and treatment. Interactome networks, especially protein-protein interaction networks, had been used to disease genes identification based on the hypothesis that strong candidate genes tend to closely relate to each other in some kinds of measure on the network. We proposed a new measure to analyze the relationship between network nodes which was called graphlet interaction. The graphlet interaction contained 28 different isomers. The results showed that the numbers of the graphlet interaction isomers between disease genes in interactome networks were significantly larger than random picked genes, while graphlet signatures were not. Then, we designed a new type of score, based on the network properties, to identify disease genes using graphlet interaction. The genes with higher scores were more likely to be disease genes, and all candidate genes were ranked according to their scores. Then the approach was evaluated by leave-one-out cross-validation. The precision of the current approach achieved 90% at about 10% recall, which was apparently higher than the previous three predominant algorithms, random walk, Endeavour and neighborhood based method. Finally, the approach was applied to predict new disease genes related to 4 common diseases, most of which were identified by other independent experimental researches. In conclusion, we demonstrate that the graphlet interaction is an effective tool to analyze the network properties of disease genes, and the scores calculated by graphlet interaction is more precise in identifying disease genes.

Citing Articles

MFIDMA: A Multiple Information Integration Model for the Prediction of Drug-miRNA Associations.

Guan Y, Yu C, Qiao Y, Li L, You Z, Ren Z Biology (Basel). 2023; 12(1).

PMID: 36671734 PMC: 9855084. DOI: 10.3390/biology12010041.


Identification of miRNA-Small Molecule Associations by Continuous Feature Representation Using Auto-Encoders.

Abdelbaky I, Tayara H, Chong K Pharmaceutics. 2022; 14(1).

PMID: 35056899 PMC: 8780428. DOI: 10.3390/pharmaceutics14010003.


Prediction of Potential Small Molecule-Associated MicroRNAs Using Graphlet Interaction.

Guan N, Sun Y, Ming Z, Li J, Chen X Front Pharmacol. 2018; 9:1152.

PMID: 30374302 PMC: 6196296. DOI: 10.3389/fphar.2018.01152.


From homogeneous to heterogeneous network alignment via colored graphlets.

Gu S, Johnson J, Faisal F, Milenkovic T Sci Rep. 2018; 8(1):12524.

PMID: 30131590 PMC: 6104050. DOI: 10.1038/s41598-018-30831-w.


GIMDA: Graphlet interaction-based MiRNA-disease association prediction.

Chen X, Guan N, Li J, Yan G J Cell Mol Med. 2017; 22(3):1548-1561.

PMID: 29272076 PMC: 5824414. DOI: 10.1111/jcmm.13429.


References
1.
Xu J, Li Y . Discovering disease-genes by topological features in human protein-protein interaction network. Bioinformatics. 2006; 22(22):2800-5. DOI: 10.1093/bioinformatics/btl467. View

2.
Keshava Prasad T, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S . Human Protein Reference Database--2009 update. Nucleic Acids Res. 2008; 37(Database issue):D767-72. PMC: 2686490. DOI: 10.1093/nar/gkn892. View

3.
Przulj N . Biological network comparison using graphlet degree distribution. Bioinformatics. 2007; 23(2):e177-83. DOI: 10.1093/bioinformatics/btl301. View

4.
Yu Y, Okayasu R, Weil M, Silver A, McCarthy M, Zabriskie R . Elevated breast cancer risk in irradiated BALB/c mice associates with unique functional polymorphism of the Prkdc (DNA-dependent protein kinase catalytic subunit) gene. Cancer Res. 2001; 61(5):1820-4. View

5.
Lage K, Karlberg E, Storling Z, Olason P, Pedersen A, Rigina O . A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol. 2007; 25(3):309-16. DOI: 10.1038/nbt1295. View